The heme oxygenase system suppresses perirenal visceral adiposity, abates renal inflammation and ameliorates diabetic nephropathy in zucker diabetic fatty rats

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Ndisang, Joseph Fomusi ^a   Jadhav, Ashok ^a   Mishra, Manish ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTANE; ADIPONECTIN; ATRIAL NATRIURETIC FACTOR; COLLAGEN; CYCLIC GMP; ENDOTHELIN 1; HEME OXYGENASE; HEMIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 1; MACROPHAGE INFLAMMATORY PROTEIN 2; NEPHRIN; STANNSOPORFIN; TUMOR NECROSIS FACTOR ALPHA;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; CYTOKINE PRODUCTION; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DRUG MECHANISM; DRUG SELECTIVITY; GLUCOSE METABOLISM; IMMUNOHISTOCHEMISTRY; ION TRANSPORT; MALE; MOLECULAR MECHANICS; NEPHRITIS; NONHUMAN; OBESITY; PROTEIN EXPRESSION; PROTEINURIA; RAT; RISK ASSESSMENT; UPREGULATION; ZUCKER DIABETIC FATTY RAT;

ADIPOSITY; ANIMALS; ATRIAL NATRIURETIC FACTOR; BLOOD GLUCOSE; CHEMOKINE CCL3; DIABETIC NEPHROPATHIES; DINOPROST; ENDOTHELIN-1; EXTRACELLULAR MATRIX PROTEINS; HEME OXYGENASE (DECYCLIZING); HEMIN; INFLAMMATION; INTERLEUKINS; KIDNEY; MACROPHAGES; MALE; RATS; RATS, ZUCKER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84897531813     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087936     Document Type: Article

References (85)

1. Hossain P, Kawar B, El Nahas M (2007) Obesity and diabetes in the developing world - a growing challenge. N Engl J Med 356: 213-215. (Pubitemid 46143224)
2. WHO (2006) Obesity and overweight. Fact Sheet No. 311, World Health Organization.
3. Ford ES, Mokdad AH, Giles WH (2003) Trends in waist circumference among U.S. adults. Obes Res 11: 1223-1231. (Pubitemid 41127376)
4. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, et al. (2003) Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. Jama 289: 76-79. (Pubitemid 36026281)
5. Odermatt A (2011) The Western-style diet: a major risk factor for impaired kidney function and chronic kidney disease. Am J Physiol Renal Physiol 301: F919-931.
6. Tiwari S, Ndisang JF (2013) The Role of Obesity in Cardiomyopathy And Nephropathy. Curr Pharm Des.
7. Giunti S, Barit D, Cooper ME (2006) Mechanisms of diabetic nephropathy: role of hypertension. Hypertension 48: 519-526. (Pubitemid 44843845)
8. Ting SM, Nair H, Ching I, Taheri S, Dasgupta I (2009) Overweight, obesity and chronic kidney disease. Nephron Clin Pract 112: c121-127; discussion c127.
9. Lamacchia O, Nicastro V, Camarchio D, Valente U, Grisorio R, et al. (2011) Para- and perirenal fat thickness is an independent predictor of chronic kidney disease, increased renal resistance index and hyperuricaemia in type-2 diabetic patients. Nephrol Dial Transplant 26: 892-898.
10. Hamdy O, Porramatikul S, Al-Ozairi E (2006) Metabolic obesity: the paradox between visceral and subcutaneous fat. Curr Diabetes Rev 2: 367-373. (Pubitemid 44734225)
11. Postorino M, Marino C, Tripepi G, Zoccali C, Group CW (2009) Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease. J Am Coll Cardiol 53: 1265-1272.
12. Li Y, Takemura G, Okada H, Miyata S, Maruyama R, et al. (2006) Reduction of inflammatory cytokine expression and oxidative damage by erythropoietin in chronic heart failure. Cardiovasc Res 71: 684-694. (Pubitemid 44848006)
13. Ndisang JF (2010) Role of heme oxygenase in inflammation, insulin-signalling, diabetes and obesity. Mediators Inflamm 2010: 359732.
14. Burgess A, Li M, Vanella L, Kim DH, Rezzani R, et al. (2010) Adipocyte heme oxygenase-1 induction attenuates metabolic syndrome in both male and female obese mice. Hypertension 56: 1124-1130.
15. Pan Y, Wang Y, Cai L, Cai Y, Hu J, et al. (2012) Inhibition of high glucose-induced inflammatory response and macrophage infiltration by a novel curcumin derivative prevents renal injury in diabetic rats. Br J Pharmacol 166: 1169-1182.
16. Ndisang JF (2013) The Heme Oxygenase System Selectively Modulates Proteins Implicated in Metabolism, Oxidative Stress and Inflammation in Spontaneously Hypertensive Rats. Curr Pharm Des.
17. Sanches FM, Avesani CM, Kamimura MA, Lemos MM, Axelsson J, et al. (2008) Waist circumference and visceral fat in CKD: a cross-sectional study. Am J Kidney Dis 52: 66-73. (Pubitemid 351853257)
18. Jim B, Ghanta M, Qipo A, Fan Y, Chuang PY, et al. (2012) Dysregulated nephrin in diabetic nephropathy of type 2 diabetes: a cross sectional study. PLoS One 7: e36041.
19. Wang Y, Wang DH (2011) Protective effect of TRPV1 against renal fibrosis via inhibition of TGF-beta/Smad signaling in DOCA-salt hypertension. Mol Med 17: 1204-1212.
20. Marshall SM (2007) The podocyte: a potential therapeutic target in diabetic nephropathy? Curr Pharm Des 13: 2713-2720.
21. Menne J, Meier M, Park JK, Boehne M, Kirsch T, et al. (2006) Nephrin loss in experimental diabetic nephropathy is prevented by deletion of protein kinase C alpha signaling in-vivo. Kidney Int 70: 1456-1462. (Pubitemid 44527315)
22. Satchell SC, Tooke JE (2008) What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium? Diabetologia 51: 714-725.
23. Ndisang JF, Lane N, Jadhav A (2009) The heme oxygenase system abates hyperglycemia in Zucker diabetic fatty rats by potentiating insulin-sensitizing pathways. Endocrinology 150: 2098-2108.
24. Salley TN, Mishra M, Tiwari S, Jadhav A, Ndisang JF (2013) The heme oxygenase system rescues hepatic deterioration in the condition of obesity co-morbid with type-2 diabetes. PLoS One 8: e79270.
25. Finucane OM, Reynolds CM, McGillicuddy FC, Roche HM (2012) Insights into the role of macrophage migration inhibitory factor in obesity and insulin resistance. Proc Nutr Soc: 1-12.
26. Lawrence T, Natoli G (2011) Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol 11: 750-761.
27. Jing F, Mogi M, Min LJ, Ohshima K, Nakaoka H, et al. (2013) Effect of Angiotensin II Type 2 Receptor-Interacting Protein on Adipose Tissue Function via Modulation of Macrophage Polarization. PLoS One 8: e60067.
28. Kim DH, Sandoval D, Reed JA, Matter EK, Tolod EG, et al. (2008) The role of GM-CSF in adipose tissue inflammation. Am J Physiol Endocrinol Metab 295: E1038-1046.
29. Jadhav A, Tiwari S, Lee P, Ndisang JF (2013) The heme oxygenase system selectively enhances the anti-inflammatory macrophage-m2 phenotype, reduces pericardial adiposity, and ameliorated cardiac injury in diabetic cardiomyopathy in zucker diabetic Fatty rats. J Pharmacol Exp Ther 345: 239-249.
30. Ndisang JF, Jadhav A (2013) Hemin therapy suppresses inflammation and retroperitoneal adipocyte hypertrophy to improve glucose metabolism in obese rats co-morbid with insulin resistant type-2 diabetes. Diabetes Obes Metab.
31. Ndisang JF, Jadhav A (2009) Heme oxygenase system enhances insulin sensitivity and glucose metabolism in streptozotocin-induced diabetes. Am J Physiol Endocrinol Metab 296: E829-841.
32. Ndisang JF, Jadhav A (2009) Up-regulating the hemeoxygenase system enhances insulin sensitivity and improves glucose metabolism in insulin-resistant diabetes in Goto-Kakizaki rats. Endocrinology 150: 2627-2636.
33. Ndisang JF, Lane N, Jadhav A (2009) Upregulation of the heme oxygenase system ameliorates postprandial and fasting hyperglycemia in type 2 diabetes. Am J Physiol Endocrinol Metab 296: E1029-1041.
34. Ndisang JF, Lane N, Syed N, Jadhav A (2010) Up-regulating the heme oxygenase system with hemin improves insulin sensitivity and glucose metabolism in adult spontaneously hypertensive rats. Endocrinology 151: 549-560.
35. Jadhav A, Torlakovic E, Ndisang JF (2009) Hemin therapy attenuates kidney injury in deoxycorticosterone acetate-salt hypertensive rats. Am J Physiol Renal Physiol 296: F521-F534.
36. Ndisang JF, Lane N, Jadhav A (2008) Crosstalk between the heme oxygenase system, aldosterone, and phospholipase C in hypertension. J Hypertens 26: 1188-1199. (Pubitemid 351698808)
37. Jadhav A, Torlakovic E, Ndisang JF (2008) Interaction Among Heme Oxygenase, Nuclear Factor-{kappa}B, and Transcription Activating Factors in Cardiac Hypertrophy in Hypertension. Hypertension 52: 910-917.
38. Ndisang JF, Jadhav A (2010) Heme arginate therapy enhanced adiponectin and atrial natriuretic peptide, but abated endothelin-1 with attenuation of kidney histopathological lesions in mineralocorticoid-induced hypertension. J Pharmacol Exp Ther 334: 87-98.
39. Ndisang JF, Jadhav A (2010) Heme-arginate suppresses phospholipase C and oxidative stress in the mesenteric arterioles of mineralcorticoid-induced hypertensive rats. Hypertens Res 33: 338-347.
40. Jadhav A, Ndisang JF (2012) Treatment with heme arginate alleviates adipose tissue inflammation and improves insulin sensitivity and glucose metabolism in a rat model of Human primary aldosteronism. Free Radic Biol Med 53: 2277-2286.
41. Ndisang JF, Wu L, Zhao W, Wang R (2003) Induction of heme oxygenase-1 and stimulation of cGMP production by hemin in aortic tissues from hypertensive rats. Blood 101: 3893-3900. (Pubitemid 36857864)
42. Rovira A, De Angioletti M, Camacho-Vanegas O, Liu D, Rosti V, et al. (2000) Stable in vivo expression of glucose-6-phosphate dehydrogenase (G6PD) and rescue of G6PD deficiency in stem cells by gene transfer. Blood 96: 4111-4117.
43. Notaro R, Afolayan A, Luzzatto L (2000) Human mutations in glucose 6-phosphate dehydrogenase reflect evolutionary history. Faseb J 14: 485-494. (Pubitemid 30143167)
44. Ndisang JF, Zhao W, Wang R (2002) Selective regulation of blood pressure by heme oxygenase-1 in hypertension. Hypertension 40: 315-321. (Pubitemid 35006717)
45. Delanty N, Reilly MP, Pratico D, Lawson JA, McCarthy JF, et al. (1997) 8-epi PGF2 alpha generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivo. Circulation 95: 2492-2499. (Pubitemid 27233114)
46. Ndisang JF, Wang R (2002) Novel therapeutic strategies for impaired endothelium-dependent vascular relaxation. Expert Opin Ther Patents 12: 1237-1247.
47. Fukunaga M, Yura T, Badr KF (1995) Stimulatory effect of 8-Epi-PGF2 alpha, an F2-isoprostane, on endothelin-1 release. J Cardiovasc Pharmacol 26 Suppl 3: S51-52.
48. Shirakami G, Nakao K, Saito Y, Magaribuchi T, Mukoyama M, et al. (1993) Low doses of endothelin-1 inhibit atrial natriuretic peptide secretion. Endocrinology 132: 1905-1912. (Pubitemid 23133234)
49. Benigni A, Zoja C, Zatelli C, Corna D, Longaretti L, et al. (2004) Vasopeptidase inhibitor restores the balance of vasoactive hormones in progressive nephropathy. Kidney Int 66: 1959-1965. (Pubitemid 41094320)
50. Folco EJ, Rocha VZ, Lopez-Ilasaca M, Libby P (2009) Adiponectin Inhibits Proinflammatory Signaling in Human Macrophages Independent of Interleukin-10. J Biol Chem 284: 25569-25575.
51. Kubota N, Terauchi Y, Yamauchi T, Kubota T, Moroi M, et al. (2002) Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 277: 25863-25866. (Pubitemid 34967064)
52. Sharma K, Ramachandrarao S, Qiu G, Usui HK, Zhu Y, et al. (2008) Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest 118: 1645-1656. (Pubitemid 351632369)
53. Gordon S, Martinez FO (2010) Alternative activation of macrophages: mechanism and functions. Immunity 32: 593-604.
54. Furuta T, Saito T, Ootaka T, Soma J, Obara K, et al. (1993) The role of macrophages in diabetic glomerulosclerosis. Am J Kidney Dis 21: 480-485. (Pubitemid 23160508)
55. Tesch GH (2010) Macrophages and diabetic nephropathy. Semin Nephrol 30: 290-301.
56. Ndisang JF, Jadhav A (2013) Hemin therapy improves kidney function in male streptozotocin-induced diabetic rats: Role of the heme oxygenase/atrial- natriuretic peptide/adiponectin axis. Endocrinology.
57. Aki K, Shimizu A, Masuda Y, Kuwahara N, Arai T, et al. (2010) ANG II receptor blockade enhances anti-inflammatory macrophages in anti-glomerular basement membrane glomerulonephritis. Am J Physiol Renal Physiol 298: F870-882.
58. Anzai A, Anzai T, Nagai S, Maekawa Y, Naito K, et al. (2012) Regulatory role of dendritic cells in postinfarction healing and left ventricular remodeling. Circulation 125: 1234-1245.
59. Piechota A, Goraca A (2011) Influence of nuclear factor-kappaB inhibition on endothelin-1 induced lung edema and oxidative stress in rats. J Physiol Pharmacol 62: 183-188.
60. Iwai T, Kitamoto K, Teramoto K, Machida Y, Tamada S, et al. (2008) Cobalt protoporphyrin attenuates rat obstructive nephropathy: role of cellular infiltration. Urology 72: 432-438.
61. Moro C, Klimcakova E, Lolmede K, Berlan M, Lafontan M, et al. (2007) Atrial natriuretic peptide inhibits the production of adipokines and cytokines linked to inflammation and insulin resistance in human subcutaneous adipose tissue. Diabetologia 50: 1038-1047. (Pubitemid 46559252)
62. Roson MI, Toblli JE, Della Penna SL, Gorzalczany S, Pandolfo M, et al. (2006) Renal protective role of atrial natriuretic peptide in acute sodium overload-induced inflammatory response. Am J Nephrol 26: 590-601. (Pubitemid 46143881)
63. Riba R, Patel B, Aburima A, Naseem KM (2008) Globular adiponectin increases cGMP formation in blood platelets independently of nitric oxide. J Thromb Haemost 6: 2121-2131.
64. Pandey KN (2005) Biology of natriuretic peptides and their receptors. Peptides 26: 901-932.
65. Wang Y, Kramer S, Loof T, Martini S, Kron S, et al. (2005) Stimulation of soluble guanylate cyclase slows progression in anti-thy1-induced chronic glomerulosclerosis. Kidney Int 68: 47-61. (Pubitemid 43181363)
66. Li Y, Tong X, Maimaitiyiming H, Clemons K, Cao JM, et al. (2012) Overexpression of cGMP-dependent protein kinase I (PKG-I) attenuates ischemia-reperfusion-induced kidney injury. Am J Physiol Renal Physiol 302: F561-570.
67. Mishra M, Ndisang JF (2013) A critical and comprehensive insight on heme oxygenase and related products including carbon monoxide, bilirubin, biliverdin and ferritin in type-1 and type-2 diabetes. Curr Pharm Des.
68. Tiwari S, Ndisang JF (2013) The Heme Oxygenase System and Type-1 Diabetes. Curr Pharm Des.
69. Tiwari S, Ndisang JF (2013) Heme Oxygenase System and Hypertension: A Comprehensive Insight. Curr Pharm Des.
70. Piechota M, Banach M, Irzmanski R, Misztal M, Rysz J, et al. (2007) N-terminal brain natriuretic propeptide levels correlate with procalcitonin and C-reactive protein levels in septic patients. Cell Mol Biol Lett 12: 162-175. (Pubitemid 46786625)
71. Shi-Wen X, Kennedy L, Renzoni EA, Bou-Gharios G, du Bois RM, et al. (2007) Endothelin is a downstream mediator of profibrotic responses to transforming growth factor beta in human lung fibroblasts. Arthritis Rheum 56: 4189-4194. (Pubitemid 350262347)
72. Tsukamoto O, Fujita M, Kato M, Yamazaki S, Asano Y, et al. (2009) Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure. J Am Coll Cardiol 53: 2070-2077.
73. Ballarin J, Arce Y, Torra Balcells R, Diaz Encarnacion M, Manzarbeitia F, et al. (2011) Acute renal failure associated to paroxysmal nocturnal haemoglobinuria leads to intratubular haemosiderin accumulation and CD163 expression. Nephrol Dial Transplant 26: 3408-3411.
74. Bedard EL, Jiang J, Parry N, Wang H, Liu W, et al. (2005) Peritransplant treatment with cobalt protoporphyrin attenuates chronic renal allograft rejection. Transpl Int 18: 341-349. (Pubitemid 41726899)
75. de Jesus Soares T, Volpini RA, Francescato HD, Costa RS, da Silva CG, et al. (2007) Effects of resveratrol on glycerol-induced renal injury. Life Sci 81: 647-656. (Pubitemid 47268017)
76. Keyse SM, Tyrrell RM (1989) Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite. Proc Natl Acad Sci U S A 86: 99-103. (Pubitemid 19036341)
77. Abraham NG, Kappas A (2008) Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev 60: 79-127. (Pubitemid 351439218)
78. Wei Y, Liu XM, Peyton KJ, Wang H, Johnson FK, et al. (2009) Hypochlorous acid-induced heme oxygenase-1 gene expression promotes human endothelial cell survival. Am J Physiol Cell Physiol 297: C907-915.
79. Mohri T, Ogura H, Koh T, Fujita K, Sumi Y, et al. (2006) Enhanced expression of intracellular heme oxygenase-1 in deactivated monocytes from patients with severe systemic inflammatory response syndrome. J Trauma 61: 616-623; discussion 623.
80. Ndisang JF, Tabien HE, Wang R (2004) Carbon monoxide and hypertension. J Hypertens 22: 1057-1074. (Pubitemid 38720993)
81. Jonas JC, Guiot Y, Rahier J, Henquin JC (2003) Haeme-oxygenase 1 expression in rat pancreatic beta cells is stimulated by supraphysiological glucose concentrations and by cyclic AMP. Diabetologia 46: 1234-1244. (Pubitemid 37214981)
82. Ndisang JF, Masini E, Mannaioni PF, Wang R (2002) Carbon monoxide and cardiovascular inflammation. In: R I, editor. Carbon monoxide and cardiovascular functions. Boca Raton: CPC Press. 165-180.
83. Ndisang JF, Jadhav A (2009) Upregulating the heme oxygenase system suppresses left ventricular hypertrophy in adult spontaneously hypertensive rats for 3 months. J Card Fail 15: 616-628.
84. Ndisang JF, Jadhav A (2009) The heme oxygenase system attenuates pancreatic lesions and improves insulin sensitivity and glucose metabolism in deoxycorticosterone acetate hypertension. Am J Physiol Regul Integr Comp Physiol.
85. Ndisang JF, Wang R (2003) Alterations in heme oxygenase/carbon monoxide system in pulmonary arteries in hypertension. Exp Biol Med (Maywood) 228: 557-563. (Pubitemid 37203677)